Aspira Women's Health Inc. (AWHL): Free Cash Flow
-$7.04M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$7.04M | n/m | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | -$12.15M | n/m | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | -$15.92M | n/m | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$31.30M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$27.58M | n/m | 2023-10-26, From 2021-01-01 |
| 2020-12-31 | -$15.22M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$13.10M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$9.48M | n/m | 2020-04-07, From 2018-01-01 |
| 2017-12-31 | -$8.19M | n/m | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | -$15.22M | n/m | 2018-03-13, From 2016-01-01 |
| 2015-12-31 | -$18.65M | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$17.07M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | -$8.54M | n/m | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$10.41M | n/m | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | -$15.68M | n/m | 2013-03-01, From 2011-01-01 |
| 2010-12-31 | -$21.11M | n/a | 2012-03-27, From 2010-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$7.04M | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$25.37M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | $1.22M | n/m |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$9.79M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$19.77M | n/m |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | -$213.66M | n/m |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$395.87M | n/m |
| Neogen Corp (NEOG) | 2026-05-31 | $31.90M | n/m |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | -$83.00M | n/m |
Compare AWHL, IMDX, ICCC, TKNO side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗